DE

521.94

-1.23%↓

CTAS

193.03

-1.09%↓

FDX

309.23

+0.82%↑

HEICO

339.11

-2.54%↓

DAL

68.9

+0.13%↑

DE

521.94

-1.23%↓

CTAS

193.03

-1.09%↓

FDX

309.23

+0.82%↑

HEICO

339.11

-2.54%↓

DAL

68.9

+0.13%↑

DE

521.94

-1.23%↓

CTAS

193.03

-1.09%↓

FDX

309.23

+0.82%↑

HEICO

339.11

-2.54%↓

DAL

68.9

+0.13%↑

DE

521.94

-1.23%↓

CTAS

193.03

-1.09%↓

FDX

309.23

+0.82%↑

HEICO

339.11

-2.54%↓

DAL

68.9

+0.13%↑

DE

521.94

-1.23%↓

CTAS

193.03

-1.09%↓

FDX

309.23

+0.82%↑

HEICO

339.11

-2.54%↓

DAL

68.9

+0.13%↑

Search

Cross Country Healthcare Inc

Slēgts

SektorsRūpniecība

8.92 1.25

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

8.77

Max

9.03

Galvenie mērījumi

By Trading Economics

Ienākumi

1.9M

-4.8M

Pārdošana

-24M

250M

EPS

0.03

Peļņas marža

-1.909

Darbinieki

9,605

EBITDA

86K

-993K

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+9.03% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2026. g. 3. marts

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-100M

300M

Iepriekšējā atvēršanas cena

7.67

Iepriekšējā slēgšanas cena

8.92

Ziņu noskaņojums

By Acuity

17%

83%

40 / 430 Rangs Industrials

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bullish Evidence

Cross Country Healthcare Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 22. janv. 21:55 UTC

Peļņas

Capital One Financial Posts Higher 4Q Profit As Lending Increases

2026. g. 22. janv. 23:52 UTC

Peļņas

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- Update

2026. g. 22. janv. 23:48 UTC

Tirgus saruna

Nikkei May Rise as Tensions Between U.S. and Europe Ease -- Market Talk

2026. g. 22. janv. 23:42 UTC

Tirgus saruna

Gold Edges Lower on Possible Profit-Taking -- Market Talk

2026. g. 22. janv. 23:40 UTC

Tirgus saruna

Spark NZ's Market Share Loss Concerns Bear -- Market Talk

2026. g. 22. janv. 23:30 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 22. janv. 23:30 UTC

Tirgus saruna

Genesis Energy Can Beat Newly Upgraded Earnings Goal -- Market Talk

2026. g. 22. janv. 22:37 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Capital One CEO: Brex Buy Reflects Business Payments Focus -- Market Talk

2026. g. 22. janv. 21:59 UTC

Iegādes, apvienošanās, pārņemšana

Capital One Strikes $5.15 Billion Deal for Fintech Brex -- Update

2026. g. 22. janv. 21:50 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Tech, Media & Telecom Roundup: Market Talk

2026. g. 22. janv. 21:44 UTC

Peļņas

Self-Driving Stock Mobileye Plunged After Earnings. Here's Why. -- Barrons.com

2026. g. 22. janv. 21:32 UTC

Iegādes, apvienošanās, pārņemšana

Capital One: Brex Invented Integrated Combination of Corporate Credit Cards, Spend Management Software and Banking in Single Platform >COF

2026. g. 22. janv. 21:31 UTC

Iegādes, apvienošanās, pārņemšana

Capital One: Brex Is a Modern, AI-native Software Platform Offering Intelligent Finance Solutions >COF

2026. g. 22. janv. 21:31 UTC

Iegādes, apvienošanās, pārņemšana

Capital One: Franceschi Will Continue to Lead Brex as Part of Capital One >COF

2026. g. 22. janv. 21:30 UTC

Iegādes, apvienošanās, pārņemšana

Capital One to Acquire Brex in Combination of Stk and Cash Transaction Valued at $5.15 B >COF

2026. g. 22. janv. 21:30 UTC

Peļņas

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results -- WSJ

2026. g. 22. janv. 21:30 UTC

Iegādes, apvienošanās, pārņemšana

Capital One To Acquire Brex >COF

2026. g. 22. janv. 21:13 UTC

Peļņas

Intel Returns to Losses in Q4 as It Ramps Up Spending on Chip Production -- WSJ

2026. g. 22. janv. 21:11 UTC

Peļņas

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

2026. g. 22. janv. 21:11 UTC

Peļņas

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

2026. g. 22. janv. 21:10 UTC

Peļņas

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

2026. g. 22. janv. 21:06 UTC

Peļņas

Capital One 4Q Total Non-Interest Expense Increased 13% to $9.3B >COF

2026. g. 22. janv. 21:05 UTC

Peļņas

Capital One 4Q Provision for Credit Losses Increased $4.1B >COF

2026. g. 22. janv. 21:05 UTC

Peļņas

Capital One 4Q Rev $15.58B >COF

2026. g. 22. janv. 21:05 UTC

Peļņas

Capital One 4Q EPS $3.26 >COF

2026. g. 22. janv. 21:05 UTC

Peļņas

Capital One 4Q Net Interest Margin 8.26% >COF

2026. g. 22. janv. 21:05 UTC

Peļņas

Capital One 4Q Net $2.13B >COF

2026. g. 22. janv. 21:05 UTC

Peļņas

Capital One 4Q Adj EPS $3.86 >COF

2026. g. 22. janv. 21:05 UTC

Peļņas

Capital One 4Q Net Charge-Offs $3.8B >COF

2026. g. 22. janv. 21:05 UTC

Peļņas

Intuitive Surgical 4Q EPS $2.21 >ISRG

Salīdzinājums

Cenas izmaiņa

Cross Country Healthcare Inc Prognoze

Cenas mērķis

By TipRanks

9.03% augšup

Prognoze 12 mēnešiem

Vidējais 9.66 USD  9.03%

Augstākais 11 USD

Zemākais 8.65 USD

Pamatojoties uz 8 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Cross Country Healthcare Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

8 ratings

1

Pirkt

7

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

13.52 / 13.92Atbalsts un pretestība

Īstermiņā

Very Strong Bullish Evidence

Vidējā termiņā

Strong Bearish Evidence

Ilgtermiņā

Bearish Evidence

Noskaņojums

By Acuity

40 / 430 Rangs Rūpniecība

Ziņu noskaņojums

Ļoti spēcīga liecība "buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Cross Country Healthcare Inc

Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services. It also offers staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, VMS, in- home care, education healthcare, RPO, project management, and other outsourcing and consultative services. This segment provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. It serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. Its Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand on temporary assignments. It serves various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.
help-icon Live chat